Veradermics (MANE), a developer of an oral hair loss therapy, has priced its upsized IPO at $17.00 per share, offering 15,077,647 shares, with all shares sold by the company. The offering is expected ...

Veradermics (MANE), a developer of an oral hair loss therapy, has filed to sell 13.4M shares of its common stock in its U.S. initial public offering under the ticker symbol “MANE,” seeking a valuation ...